Becker Capital Management Inc Edwards Lifesciences Corp Transaction History

Becker Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $174,217 - $201,866	2,140 Added 9.06%	25,764 $2.43 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $247,582 - $281,756	3,334 Added 16.43%	23,624 $1.95 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $814,750 - $1.04 Million	11,929 Added 142.67%	20,290 $1.51 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $62,848 - $81,862	763 Added 10.04%	8,361 $691,000
Q2 2022 Aug 04, 2022	BUY	$86.5 - $128.27 $657,227 - $974,595	7,598 New	7,598 $722,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Becker Capital Management Inc with notifications on news.